FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W1995777819> ?p ?o ?g. }

• W1995777819 endingPage "824" @default.
• W1995777819 startingPage "815" @default.
• W1995777819 abstract "The temporal variation in bone marrow proliferation has been used to help define the optimal time of day to dose with approximately 30 chemotherapeutic agents, so that treatment efficacy is maximised and toxicity is minimised. Since myelosuppression is also the dose-limiting toxicity for most forms of radioimmunotherapy, we hypothesised that time of day of administration might also influence tolerance for radioantibody therapy. Bone marrow proliferative activity in BALB/c mice was determined using cell cycle analysis of propidium iodide-stained bone marrow samples collected at 3 h intervals. Myelosuppression was determined at weekly intervals after a therapeutic dose of 131I-NP-4 anti-CEA (carcinoembryonic antigen) intact IgG at either 0900 h (2 h after light onset [HALO]), 1300 h (6 HALO) or 1600 h (9 HALO). The highest bone marrow proliferative activity was noted between 20 HALO (0300 h) and 4 HALO (1100 h), and the lowest activity could be measured at 10-13 HALO (1700-2000 h). Seven days after a maximal tolerated dose (MTD) of radioantibody, granulocyte reduction was 50% at both 2 and 6 HALO and only 32% at 9 HALO (P < 0.003). Fourteen days after radioantibody therapy, an 87% granulocyte suppression was observed in mice treated at 2 HALO and only a 64% granulocyte loss was noted in the 9 HALO treated group (P < 0.001). The 2 HALO group recovered earlier than the 9 HALO group (P < 0.013; 22% loss from the 2 HALO dose and 40% loss from the 9 HALO dose) on day 28 post-radioimmunotherapy. The difference in magnitude of neutropenia, rather than duration, was critical for establishing the MTD. A 30% increase in the MTD was possible if mice were dosed at 9 HALO (320 microCi) versus 2 HALO (240 microCi). These studies suggest that principles of chronobiology may govern the magnitude of toxicity and the highest dose tolerated in radioantibody therapy in the same way that it does for cytotoxic drug therapy." @default.
• W1995777819 created "2016-06-24" @default.
• W1995777819 creator A5003890903 @default.
• W1995777819 creator A5013954632 @default.
• W1995777819 creator A5014069714 @default.
• W1995777819 creator A5016548721 @default.
• W1995777819 creator A5051963794 @default.
• W1995777819 creator A5068625015 @default.
• W1995777819 date "1999-05-01" @default.
• W1995777819 modified "2023-09-26" @default.
• W1995777819 title "Chronotolerance of experimental radioimmunotherapy: clearance, toxicity, and maximal tolerated dose of 131I-anti-carcinoembryonic antigen (CEA) IgG as a function of time of day of dosing in a murine model" @default.
• W1995777819 cites W1628377054 @default.
• W1995777819 cites W1905047988 @default.
• W1995777819 cites W1945215925 @default.
• W1995777819 cites W1964471568 @default.
• W1995777819 cites W1976520588 @default.
• W1995777819 cites W1989230609 @default.
• W1995777819 cites W2000093975 @default.
• W1995777819 cites W2004644919 @default.
• W1995777819 cites W2060819146 @default.
• W1995777819 cites W2071919142 @default.
• W1995777819 cites W2084493022 @default.
• W1995777819 cites W2084934811 @default.
• W1995777819 cites W2095584858 @default.
• W1995777819 cites W2318431083 @default.
• W1995777819 cites W2320751441 @default.
• W1995777819 doi "https://doi.org/10.1016/s0959-8049(98)00432-8" @default.
• W1995777819 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/10505044" @default.
• W1995777819 hasPublicationYear "1999" @default.
• W1995777819 type Work @default.
• W1995777819 sameAs 1995777819 @default.
• W1995777819 citedByCount "5" @default.
• W1995777819 countsByYear W19957778192014 @default.
• W1995777819 countsByYear W19957778192019 @default.
• W1995777819 crossrefType "journal-article" @default.
• W1995777819 hasAuthorship W1995777819A5003890903 @default.
• W1995777819 hasAuthorship W1995777819A5013954632 @default.
• W1995777819 hasAuthorship W1995777819A5014069714 @default.
• W1995777819 hasAuthorship W1995777819A5016548721 @default.
• W1995777819 hasAuthorship W1995777819A5051963794 @default.
• W1995777819 hasAuthorship W1995777819A5068625015 @default.
• W1995777819 hasConcept C121332964 @default.
• W1995777819 hasConcept C121608353 @default.
• W1995777819 hasConcept C126322002 @default.
• W1995777819 hasConcept C159654299 @default.
• W1995777819 hasConcept C184665706 @default.
• W1995777819 hasConcept C203014093 @default.
• W1995777819 hasConcept C2776146153 @default.
• W1995777819 hasConcept C2776694085 @default.
• W1995777819 hasConcept C2777288759 @default.
• W1995777819 hasConcept C2777387746 @default.
• W1995777819 hasConcept C2777767877 @default.
• W1995777819 hasConcept C2777983669 @default.
• W1995777819 hasConcept C2780007613 @default.
• W1995777819 hasConcept C29730261 @default.
• W1995777819 hasConcept C542903549 @default.
• W1995777819 hasConcept C62520636 @default.
• W1995777819 hasConcept C71924100 @default.
• W1995777819 hasConcept C90924648 @default.
• W1995777819 hasConcept C98444146 @default.
• W1995777819 hasConceptScore W1995777819C121332964 @default.
• W1995777819 hasConceptScore W1995777819C121608353 @default.
• W1995777819 hasConceptScore W1995777819C126322002 @default.
• W1995777819 hasConceptScore W1995777819C159654299 @default.
• W1995777819 hasConceptScore W1995777819C184665706 @default.
• W1995777819 hasConceptScore W1995777819C203014093 @default.
• W1995777819 hasConceptScore W1995777819C2776146153 @default.
• W1995777819 hasConceptScore W1995777819C2776694085 @default.
• W1995777819 hasConceptScore W1995777819C2777288759 @default.
• W1995777819 hasConceptScore W1995777819C2777387746 @default.
• W1995777819 hasConceptScore W1995777819C2777767877 @default.
• W1995777819 hasConceptScore W1995777819C2777983669 @default.
• W1995777819 hasConceptScore W1995777819C2780007613 @default.
• W1995777819 hasConceptScore W1995777819C29730261 @default.
• W1995777819 hasConceptScore W1995777819C542903549 @default.
• W1995777819 hasConceptScore W1995777819C62520636 @default.
• W1995777819 hasConceptScore W1995777819C71924100 @default.
• W1995777819 hasConceptScore W1995777819C90924648 @default.
• W1995777819 hasConceptScore W1995777819C98444146 @default.
• W1995777819 hasIssue "5" @default.
• W1995777819 hasLocation W19957778191 @default.
• W1995777819 hasLocation W19957778192 @default.
• W1995777819 hasOpenAccess W1995777819 @default.
• W1995777819 hasPrimaryLocation W19957778191 @default.
• W1995777819 hasRelatedWork W1517145497 @default.
• W1995777819 hasRelatedWork W1975585547 @default.
• W1995777819 hasRelatedWork W1979022699 @default.
• W1995777819 hasRelatedWork W1995777819 @default.
• W1995777819 hasRelatedWork W2082990692 @default.
• W1995777819 hasRelatedWork W2093273184 @default.
• W1995777819 hasRelatedWork W2364265187 @default.
• W1995777819 hasRelatedWork W2410548550 @default.
• W1995777819 hasRelatedWork W2435675553 @default.
• W1995777819 hasRelatedWork W3156918675 @default.
• W1995777819 hasVolume "35" @default.
• W1995777819 isParatext "false" @default.
• W1995777819 isRetracted "false" @default.
• W1995777819 magId "1995777819" @default.

• next